Journal Cover Interventional Cardiology Clinics
  [SJR: 0.253]   [H-I: 4]   [3 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 2211-7458 - ISSN (Online) 2211-7466
   Published by Elsevier Homepage  [3034 journals]
  • Invasive Hemodynamics of Pericardial Disease
    • Authors: Ganesh Athappan; Paul Sorajja
      Pages: 309 - 317
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Ganesh Athappan, Paul Sorajja
      Teaser Pericardial diseases can be classified broadly as 3 entities: acute pericarditis, cardiac tamponade, and constrictive pericarditis. These disorders can be diagnosed and managed with noninvasive studies following a comprehensive history and physical examination, without the need for cardiac catheterization in most patients. Despite the advances in noninvasive cardiac imaging, there are limitations to their diagnostic accuracy. The invasive hemodynamic study offers the advantage of simultaneous, direct pressure measurement across multiple chambers, with direct examination of blood flow. Herein, the authors review the techniques for obtaining and interpreting invasive hemodynamic data in patients with suspected pericardial disease.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.002
       
  • Invasive Hemodynamics of Pulmonary Disease and the Right Ventricle
    • Authors: David Silber; Justine Lachmann
      Pages: 329 - 343
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): David Silber, Justine Lachmann
      Teaser Pulmonary hypertension (PH) falls into 5 groups, as defined by the World Health Organization. Swan-Ganz catheters determine precapillary versus postcapillary PH. The hemodynamic values of PH at rest and with vasodilatory challenge categorize the etiology of PH and guide treatment. RV maladaptations to increased pulmonary vascular resistance (PVR) and the chronicity of the right ventricle's (RV) response to increased PH and/or increased PVR can be understood with pressure-volume (PV) loops constructed with use of conductance catheters. These PV loops demonstrate the RV's ability to increase stroke volume in acutely and chronically increased PVR.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.004
       
  • Invasive Hemodynamics of Adult Congenital Heart Disease
    • Authors: Surendranath R. Veeram Reddy; Alan W. Nugent; Thomas M. Zellers; V. Vivian Dimas
      Pages: 345 - 358
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Surendranath R. Veeram Reddy, Alan W. Nugent, Thomas M. Zellers, V. Vivian Dimas
      Teaser Adults with congenital heart disease are a growing population with increasingly more complex disease, in large part due to improvements in delivery of care to the pediatric population. Cardiac catheterization is an integral component of diagnosis and management in these patients. Careful attention to detail and a thorough understanding of intracardiac hemodynamics are critical to performing complete diagnostic evaluations. This article outlines the most commonly encountered lesions with guidelines for invasive assessment to help guide further therapy.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.005
       
  • Hemodynamics of Cardiogenic Shock
    • Authors: Ariel Furer; Jeffrey Wessler; Daniel Burkhoff
      Pages: 359 - 371
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Ariel Furer, Jeffrey Wessler, Daniel Burkhoff
      Teaser Cardiogenic shock (CS) represents an advanced state of morbidity along the pathophysiologic pathway of end-organ hypoperfusion caused by reduced cardiac output and blood pressure. Acute coronary syndromes remain the most common cause of CS. The spectrum of hypoperfusion states caused by low cardiac output ranges from pre-CS to refractory CS and can be characterized by an array of hemodynamic parameters. This review provides the foundation for a hemodynamic understanding of CS including the use of hemodynamic monitoring for diagnosis and treatment, the cardiac and vascular determinants of CS, and a hemodynamic approach to risk stratification and management of CS.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.006
       
  • Transcatheter Aortic Valve Replacement and MitraClip to Reverse Heart
           Failure
    • Authors: Sukhdeep Basra; Molly Szerlip
      Pages: 373 - 386
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Sukhdeep Basra, Molly Szerlip
      Teaser Valvular heart diseases such as aortic stenosis and mitral regurgitation are often associated with heart failure, which in turn increases patients’ Surgical Thoracic Society (STS) score. A high STS score means the patient is high risk for surgical aortic valve replacement and mitral valve repair/replacement. Transcatheter aortic valve replacement and percutaneous mitral valve repair offer a minimally invasive alternative for the treatment of valvular heart disease in patients with severe heart failure. We aim to review the current evidence on the safety, efficacy, and outcomes of these devices in patients with severe heart failure.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.007
       
  • Mechanical Circulatory Support in Acute Decompensated Heart Failure and
           Shock
    • Authors: Nishtha Sodhi; John M. Lasala
      Pages: 387 - 405
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Nishtha Sodhi, John M. Lasala
      Teaser An array of interventional therapeutics is available in the modern era, with uses depending on acute or chronic situations. This article focuses on support in acute decompensated heart failure and cardiogenic shock, including intra-aortic balloon pumps, continuous aortic flow augmentation, and extra-corporeal membrane oxygenation.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.008
       
  • Multivessel Revascularization in Shock and High-Risk Percutaneous Coronary
           Intervention
    • Authors: Sandeep K. Krishnan; Robert F. Riley; Ravi S. Hira; William L. Lombardi
      Pages: 407 - 416
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Sandeep K. Krishnan, Robert F. Riley, Ravi S. Hira, William L. Lombardi
      Teaser This review explores the usefulness of multivessel revascularization with percutaneous coronary intervention in patients with multivessel obstructive coronary artery disease (CAD) presenting with and without cardiogenic shock. We also evaluate the literature regarding complete versus incomplete revascularization for patients with cardiogenic shock, acute coronary syndromes, and stable coronary artery disease.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.009
       
  • Adult Congenital Interventions in Heart Failure
    • Authors: Hussam S. Suradi; Ziyad M. Hijazi
      Pages: 427 - 443
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Hussam S. Suradi, Ziyad M. Hijazi
      Teaser Congenital heart disease (CHD) is the most common birth defect, occurring in approximately 0.8% to 1.0% of neonates. Advances in medical and surgical therapies for children with CHD have resulted in a growing population of patients reaching adulthood, with survival rates exceeding 85%. Many of these patients, especially if managed inappropriately, face the prospect of future complications including heart failure and premature death. For adults with uncorrected or previously palliated CHD, percutaneous therapies have become the primary treatment for many forms of CHD. In this article, we discuss the role of transcatheter interventions in the treatment of adults with CHD.

      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/j.iccl.2017.03.011
       
  • Endovascular Treatment of Peripheral Artery Disease and Critical Limb
           Ischemia
    • Authors: Ehrin J. Armstrong
      Abstract: Publication date: April 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 2
      Author(s): Ehrin J. Armstrong


      PubDate: 2017-03-05T21:37:23Z
      DOI: 10.1016/j.iccl.2017.01.001
       
  • Mechanisms Underlying Drug Delivery to Peripheral Arteries
    • Authors: Jun Li; Rami Tzafriri; Sandeep M. Patel; Sahil A. Parikh
      Pages: 197 - 216
      Abstract: Publication date: April 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 2
      Author(s): Jun Li, Rami Tzafriri, Sandeep M. Patel, Sahil A. Parikh
      Teaser Delivery of drugs onto arterial targets via endovascular devices commands several principles: dissolution, diffusion, convection, drug binding, barriers to absorption, and interaction between the drug, delivery vehicle, and accepting arterial wall. The understanding of drug delivery in the coronary vasculature is vast; there is ongoing work needed in the peripheral arteries. There are differences that account for some failures of application of coronary technology into the peripheral vascular space. Breakthroughs in peripheral vascular interventional techniques building on current technologies require investigators willing to acknowledge the similarities and differences between these different vascular territories, while developing technologies adapted for peripheral arteries.

      PubDate: 2017-03-05T21:37:23Z
      DOI: 10.1016/j.iccl.2016.12.004
       
  • Current Role of Atherectomy for Treatment of Femoropopliteal and
           Infrapopliteal Disease
    • Authors: Nicolas W. Shammas
      Pages: 235 - 249
      Abstract: Publication date: April 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 2
      Author(s): Nicolas W. Shammas
      Teaser Atherectomy improves the acute procedural success of a procedure whether treating de novo or restenotic (including in-stent) disease. Intermediate follow-up results seem to be in favor of atherectomy in delaying and reducing the need for repeat revascularization in patients with femoropopliteal in-stent restenosis. Recent data suggest that avoiding cutting into the external elastic lamina is an important factor in reducing restenosis. The interplay between directional atherectomy and drug-coated balloons is unclear.

      PubDate: 2017-03-05T21:37:23Z
      DOI: 10.1016/j.iccl.2016.12.007
       
  • Angiosome-Guided Intervention in Critical Limb Ischemia
    • Authors: Matthew C. Bunte; Mehdi H. Shishehbor
      Pages: 271 - 277
      Abstract: Publication date: April 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 2
      Author(s): Matthew C. Bunte, Mehdi H. Shishehbor
      Teaser The goals of treatment for critical limb ischemia (CLI) are alleviation of ischemic rest pain, healing of arterial insufficiency ulcers, and improving quality of life, thereby preventing limb loss and CLI-related mortality. Arterial revascularization is the foundation of a contemporary approach to promote amputation-free survival. Angiosome-directed revascularization has become a popular theory of reperfusion, whereby anatomically directed arterial flow is restored straight to the wound bed. Innovations in endovascular revascularization combined with a multidisciplinary strategy of wound care accelerate progress in CLI management. This article highlights advances in CLI management, including the clinical relevance of angiosome-directed revascularization, and provides considerations for future treatment of CLI.

      PubDate: 2017-03-05T21:37:23Z
      DOI: 10.1016/j.iccl.2016.12.010
       
  • Interventional Cardiology Clinics
    • Authors: Matthew J. Price
      Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3
      Author(s): Matthew J. Price


      PubDate: 2017-06-08T17:45:33Z
      DOI: 10.1016/s2211-7458(16)30135-3
       
  • Interventional Cardiology Clinics
    • Authors: Matthew J. Price
      Abstract: Publication date: April 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 2
      Author(s): Matthew J. Price


      PubDate: 2017-03-05T21:37:23Z
      DOI: 10.1016/s2211-7458(16)30135-3
       
  • Interventional Heart Failure
    • Abstract: Publication date: July 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 3


      PubDate: 2017-06-08T17:45:33Z
       
  • Prioritizing and Combining Therapies for Heart Failure in the Era of
           Mechanical Support Devices
    • Authors: George S. Hanzel; Simon Dixon; James A. Goldstein
      Abstract: Publication date: Available online 10 May 2017
      Source:Interventional Cardiology Clinics
      Author(s): George S. Hanzel, Simon Dixon, James A. Goldstein
      Teaser Technological advances have promoted challenges to prioritizing and combining therapies for heart failure. The concept of prioritization implies distinct but inextricably linked considerations. They may be viewed from pathophysiologic, clinical, and procedural perspectives, encompassing analysis of hemodynamic status, anatomic considerations, and technical challenges. It is essential to consider factors, including conduction disease, renal and pulmonary function, hematological derangements, and so forth. These considerations allow determination of clinical goals, which determine prioritization and interventional strategies. These considerations then facilitate goal setting for medical and interventional therapies as definitive/destination, preservation/salvage, stepwise, bridge, or palliation.

      PubDate: 2017-05-15T04:18:48Z
      DOI: 10.1016/j.iccl.2017.03.015
       
  • Operationalizing Interventional Heart Failure: Adding Substance to the
           Concept
    • Authors: Srihari S. Naidu
      Abstract: Publication date: Available online 2 May 2017
      Source:Interventional Cardiology Clinics
      Author(s): Srihari S. Naidu


      PubDate: 2017-05-05T01:34:41Z
      DOI: 10.1016/j.iccl.2017.04.001
       
  • Cardiac Resynchronization Therapy for Heart Failure
    • Authors: Amole Ojo; Sohaib Tariq; Prakash Harishkrishnan; Sei Iwai; Jason T. Jacobson
      Abstract: Publication date: Available online 26 April 2017
      Source:Interventional Cardiology Clinics
      Author(s): Amole Ojo, Sohaib Tariq, Prakash Harishkrishnan, Sei Iwai, Jason T. Jacobson
      Teaser Cardiac resynchronization therapy (CRT) has emerged as a valued nonpharmacologic therapy in patients with heart failure, reduced ejection fraction (EF), and ventricular dyssynchrony manifest as left bundle branch block. The mechanisms of benefit include remodeling of the left ventricle leading to decreased dimensions and increased EF, as well as a decrease in the severity of mitral regurgitation. This article reviews the rationale, effects, and indications for CRT, and discusses the patient characteristics that predict response and considerations for nonresponders.

      PubDate: 2017-04-27T22:58:03Z
      DOI: 10.1016/j.iccl.2017.03.010
       
  • Renal Denervation to Modify Hypertension and the Heart Failure State
    • Authors: Ming Zhong; Luke K. Kim; Rajesh V. Swaminathan; Dmitriy N. Feldman
      Abstract: Publication date: Available online 26 April 2017
      Source:Interventional Cardiology Clinics
      Author(s): Ming Zhong, Luke K. Kim, Rajesh V. Swaminathan, Dmitriy N. Feldman
      Teaser Sympathetic overactivation of renal afferent and efferent nerves have been implicated in the development and maintenance of several cardiovascular disease states, including resistant hypertension and heart failure with both reduced and preserved systolic function. With the development of minimally invasive catheter-based techniques, percutaneous renal denervation has become a safe and effective method of attenuating sympathetic overactivation. Percutaneous renal denervation, therefore, has the potential to modify and treat hypertension and congestive heart failure. Although future randomized controlled studies are needed to definitively prove its efficacy, renal denervation has the potential to change the way we view and treat cardiovascular disease.

      PubDate: 2017-04-27T22:58:03Z
      DOI: 10.1016/j.iccl.2017.03.013
       
  • Invasive Hemodynamics of Valvular Heart Disease
    • Authors: Michele Pighi; Anita W. Asgar
      Abstract: Publication date: Available online 25 April 2017
      Source:Interventional Cardiology Clinics
      Author(s): Michele Pighi, Anita W. Asgar
      Teaser In the current era, diagnosis and follow-up of valvular heart disease is performed noninvasively using echocardiography. In some cases, the results of echocardiographic evaluation are inconclusive or discrepant with the patient’s clinical symptoms. In such cases, a well-planned and executed cardiac catheterization is invaluable to clarify the clinical dilemma and assist in planning further management. This article reviews the indications, technique, and interpretation of cardiac catheterization in the setting of valvular stenosis and regurgitation.

      PubDate: 2017-04-27T22:58:03Z
      DOI: 10.1016/j.iccl.2017.03.003
       
  • Integrating Interventional Cardiology and Heart Failure Management for
           Cardiogenic Shock
    • Authors: Navin K. Kapur; Carlos D. Davila; Marwan F. Jumean
      Abstract: Publication date: Available online 22 April 2017
      Source:Interventional Cardiology Clinics
      Author(s): Navin K. Kapur, Carlos D. Davila, Marwan F. Jumean
      Teaser Cardiogenic shock remains one of the most common causes of in-hospital death. Recent data have identified an overall increase in patient complexity, with cardiogenic shock in the setting of acute myocardial infarction. The use of percutaneous acute mechanical circulatory support (AMCS) has steadily grown in the past decade. Guidelines and consensus statements addressing proper patient selection, timing of AMCS implantation, device choice, and postimplantation protocol are appearing. The emerging role of interventional heart failure specialists within the heart team includes integration and understanding of advanced hemodynamic and cathether-based therapies, with the goal of improving outcomes.

      PubDate: 2017-04-27T22:58:03Z
      DOI: 10.1016/j.iccl.2017.03.014
       
  • Alcohol Septal Ablation to Reduce Heart Failure
    • Authors: Joshua McKay; Sherif F. Nagueh
      Abstract: Publication date: Available online 21 April 2017
      Source:Interventional Cardiology Clinics
      Author(s): Joshua McKay, Sherif F. Nagueh
      Teaser Hypertrophic cardiomyopathy is a commonly encountered inheritable cardiac disorder with variable phenotypic expression. Although most patients will have no or mild symptoms, 10% will develop heart failure symptoms refractory to medical management. This article discusses the mechanisms through which hypertrophic cardiomyopathy induces heart failure and how alcohol septal ablation can reverse each of these mechanisms to lead to clinical improvement.

      PubDate: 2017-04-27T22:58:03Z
      DOI: 10.1016/j.iccl.2017.03.012
       
  • Invasive Hemodynamics of Myocardial Disease
    • Authors: Michael Eskander; Morton J. Kern
      Abstract: Publication date: Available online 21 April 2017
      Source:Interventional Cardiology Clinics
      Author(s): Michael Eskander, Morton J. Kern
      Teaser Heart failure is a clinical diagnosis that is supported by various laboratory, imaging, and invasive hemodynamic measures. There is no single diagnostic test. A variety of structural and/or functional myocardial abnormalities can lead to the inability of the heart to fill or eject blood. Despite ejection fraction being the most commonly assessed measure of systolic function in clinical practice, it is a poor measure of contractility because it is susceptible to loading conditions and chamber size. Invasive hemodynamic assessment remains of great importance in the evaluation of patients with myocardial disease or hypertrophic cardiomyopathy.

      PubDate: 2017-04-27T22:58:03Z
      DOI: 10.1016/j.iccl.2017.03.001
       
  • Endovascular Treatment of Peripheral Artery Disease and Critical Limb
           Ischemia
    • Abstract: Publication date: April 2017
      Source:Interventional Cardiology Clinics, Volume 6, Issue 2


      PubDate: 2017-03-05T21:37:23Z
       
  • Current Status and Outcomes of Iliac Artery Endovascular Intervention
    • Authors: Vladimir Lakhter; Vikas Aggarwal
      Abstract: Publication date: Available online 27 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Vladimir Lakhter, Vikas Aggarwal
      Teaser Aortoiliac occlusive disease (AIOD) is widely prevalent and leads to significant limitations in patient quality of life. All patients with aortoiliac occlusive disease should be managed with approved medical therapies in addition to a supervised exercise program. Persistence of significant symptoms despite noninvasive therapy should prompt further management with endovascular revascularization. Although patients with the most complex cases of AIOD anatomy may ultimately require surgery, advances in endovascular techniques have made it possible to treat most of these patients with AIOD using an endovascular-first approach.

      PubDate: 2017-02-02T02:58:26Z
      DOI: 10.1016/j.iccl.2016.12.001
       
  • Is Common Femoral Artery Stenosis Still a Surgical Disease'
    • Authors: Stephan Heo; Peter Soukas; Herbert D. Aronow
      Abstract: Publication date: Available online 27 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Stephan Heo, Peter Soukas, Herbert D. Aronow
      Teaser Surgical endarterectomy has long been the standard approach for treating atherosclerotic stenosis in the common femoral artery. Its major advantage is the associated long-term patency, which approaches 95% at 5 years. Nevertheless, recent studies have suggested that percutaneous treatment may be a valid alternative to surgery.

      PubDate: 2017-02-02T02:58:26Z
      DOI: 10.1016/j.iccl.2016.12.002
       
  • Contemporary Outcomes of Endovascular Intervention for Critical Limb
           Ischemia
    • Authors: Pratik K. Dalal; Anand Prasad
      Abstract: Publication date: Available online 27 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Pratik K. Dalal, Anand Prasad
      Teaser Critical limb ischemia (CLI) remains a significant cause of morbidity and mortality in patients with peripheral arterial disease. Optimal treatment strategies for CLI remain controversial. The only randomized trial comparing surgical with endovascular revascularization suggests no significant difference in limb salvage between open surgical bypass and angioplasty. Although novel endovascular strategies are now available, their efficacies remain largely untested in a randomized fashion. This review provides an overview of the data surrounding contemporary outcomes of endovascular therapy with an emphasis on current knowledge gaps.

      PubDate: 2017-02-02T02:58:26Z
      DOI: 10.1016/j.iccl.2016.12.008
       
  • Current Endovascular Management of Acute Limb Ischemia
    • Authors: Javier A. Valle; Stephen W. Waldo
      Abstract: Publication date: Available online 27 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Javier A. Valle, Stephen W. Waldo
      Teaser Acute limb ischemia is a vascular emergency, threatening the viability of the affected limb and requiring immediate recognition and treatment. Even with revascularization of the affected extremity, acute limb ischemia is associated with significant morbidity and mortality resulting in up to a 15% risk of amputation during the initial hospitalization and a 1 in 5 risk of mortality within 1 year of the index event. This review summarizes the current management of acute limb ischemia. Understanding the diagnosis and therapeutic options will aid clinicians in treating these critically ill patients.

      PubDate: 2017-02-02T02:58:26Z
      DOI: 10.1016/j.iccl.2016.12.003
       
  • Drug-Coated Balloons
    • Authors: Ananya Kondapalli; Barbara A. Danek; Houman Khalili; Haekyung Jeon-Slaughter; Subhash Banerjee
      Abstract: Publication date: Available online 16 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Ananya Kondapalli, Barbara A. Danek, Houman Khalili, Haekyung Jeon-Slaughter, Subhash Banerjee
      Teaser Paclitaxel-coated drug-coated balloons have significantly improved short-term and mid-term clinical outcomes in patients with symptomatic femoropopliteal peripheral artery disease. However, long-term results are awaited. Furthermore, the clinical success of drug-coated balloons in the infrapopliteal peripheral arteries has been more modest and overall similar to traditional balloon angioplasty, and remains an area of unmet clinical need. This article provides an overview of the clinical evidence for paclitaxel-coated balloons in the femoropopliteal and infrapopliteal peripheral artery distributions and future directions in this area.

      PubDate: 2017-01-19T21:53:04Z
      DOI: 10.1016/j.iccl.2016.12.005
       
  • Emerging and Future Therapeutic Options for Femoropopliteal and
           Infrapopliteal Endovascular Intervention
    • Authors: Damianos G. Kokkinidis; Ehrin J. Armstrong
      Abstract: Publication date: Available online 13 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Damianos G. Kokkinidis, Ehrin J. Armstrong
      Teaser Despite recent advances in endovascular therapy for peripheral artery disease, current technologies remain limited by rates of long-term restenosis and application to complex lesion subsets. This article presents data on upcoming therapies, including novel drug-coated balloons, drug-eluting stents, bioresorbable scaffolds, novel drug delivery therapies to target arteries, techniques to limit postangioplasty dissection, and treatment of severely calcified lesions.

      PubDate: 2017-01-19T21:53:04Z
      DOI: 10.1016/j.iccl.2016.12.011
       
  • Inframalleolar Intervention for Limb Preservation
    • Authors: Javier A. Valle; Andrew F. Prouse; Robert K. Rogers
      Abstract: Publication date: Available online 10 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Javier A. Valle, Andrew F. Prouse, Robert K. Rogers
      Teaser Critical limb ischemia (CLI) is a relatively prevalent and highly morbid condition. Patients with CLI have a poor prognosis, especially in the setting of incomplete revascularization. Traditionally, achieving optimal revascularization has been limited by the high prevalence of small-vessel disease in this population. More recently, advanced endovascular techniques, increased operator experience, and new technologies have enabled complete revascularization of inframalleolar disease with encouraging clinical results. In this article, we present an approach to endovascular therapy for inframalleolar revascularization of patients with CLI.

      PubDate: 2017-01-12T21:23:41Z
      DOI: 10.1016/j.iccl.2016.12.009
       
  • Nitinol Self-Expanding Stents for the Superficial Femoral Artery
    • Authors: Ashwin Nathan; Taisei Kobayashi; Jay Giri
      Abstract: Publication date: Available online 5 January 2017
      Source:Interventional Cardiology Clinics
      Author(s): Ashwin Nathan, Taisei Kobayashi, Jay Giri
      Teaser The superficial femoral artery is a complex artery subject to a unique set of biomechanical loading conditions in its course through the leg. Plain balloon angioplasty and balloon-expandable stents had unacceptably high rates of restenosis, necessitating target vessel revascularization. Nitinol alloy is well suited to provide the strength and flexibility needed of stents to withstand the external forces posed by the environment of the superficial femoral artery. Advances in stent technology with the addition of a slow-releasing antiproliferative agent and changes in scaffold design have shown promise in reducing the rates of stent fracture and in-stent restenosis.

      PubDate: 2017-01-12T21:23:41Z
      DOI: 10.1016/j.iccl.2016.12.006
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
Home (Search)
Subjects A-Z
Publishers A-Z
Customise
APIs
Your IP address: 54.196.107.244
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016